Across TCGA pan-cancer cohorts, MIR1272 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR1272 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MIR1272 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR1272 expression acts as an unfavorable survival marker.

UCEC, MESO, and COAD are the cancer types where MIR1272 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.835	0.903	.012	66	view →
MESO	DFS	Tertile	III,IV	0.088	0.392	<.001	54	view →
COAD	OS	Tertile	All	0.142	0.871	<.001	54	view →
UVM	OS	Tertile	All	0.280	0.796	<.001	45	view →
UCS	DFS	Tertile	IV	0.132	0.718	.002	36	view →
DLBC	DFS	Tertile	II,III,IV	0.022	0.837	<.001	36	view →
BLCA	DFS	Tertile	All	0.201	0.601	.010	27	view →
STAD	OS	Quartile	II,III,IV	0.409	0.613	.018	20	view →
KIRC	DFS	Tertile	IV	0.305	0.628	.021	18	view →
ACC	DFS	Tertile	III,IV	0.068	0.484	.003	18	view →
KICH	DFS	Tertile	All	0.600	0.911	.045	4	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

Exploration

Same gene, other analysis: MIR1272 tumor-vs-normal RNA expression · all MIR1272 data types